➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Colorcon
Mallinckrodt
Boehringer Ingelheim
Express Scripts

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pyrrole-2-Carboxylate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Pyrrole-2-Carboxylate?

Pyrrole-2-Carboxylate is an investigational drug.

There have been 5 clinical trials for Pyrrole-2-Carboxylate. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2020.

The most common disease conditions in clinical trials are Pre-Eclampsia, Melanoma, and Venous Thrombosis. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Assiut University, and Second Affiliated Hospital, School of Medicine, Zhejiang University.

There are five hundred and ninety-nine US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Pyrrole-2-Carboxylate
TitleSponsorPhase
Effect of Rosuvastatin on the Clinical Features of PreeclampsiaAssiut UniversityPhase 2
Prophylactic Anticoagulation for Catheter-related ThrombosisSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4
Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast CancerJiangsu HengRui Medicine Co., Ltd.Phase 1/Phase 2

See all Pyrrole-2-Carboxylate clinical trials

Clinical Trial Summary for Pyrrole-2-Carboxylate

Top disease conditions for Pyrrole-2-Carboxylate
Top clinical trial sponsors for Pyrrole-2-Carboxylate

See all Pyrrole-2-Carboxylate clinical trials

US Patents for Pyrrole-2-Carboxylate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyrrole-2-Carboxylate   Start Trial Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)   Start Trial
Pyrrole-2-Carboxylate   Start Trial Novel aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)   Start Trial
Pyrrole-2-Carboxylate   Start Trial 1-heterocyclic bicyclo-octanes The Wellcome Foundation Limited (London, GB2)   Start Trial
Pyrrole-2-Carboxylate   Start Trial Certain phosphonic acids and derivatives useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pyrrole-2-Carboxylate

Drugname Country Document Number Estimated Expiration Related US Patent
Pyrrole-2-Carboxylate Australia 4875690 2009-01-31   Start Trial
Pyrrole-2-Carboxylate Australia 625688 2009-01-31   Start Trial
Pyrrole-2-Carboxylate European Patent Office 0381142 2009-01-31   Start Trial
Pyrrole-2-Carboxylate Japan H02235814 2009-01-31   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Colorcon
Mallinckrodt
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.